journal article·2018-12

Aqueous Two‐Phase Emulsion Bioink‐Enabled 3D Bioprinting of Porous Hydrogels

Guo‐Liang Ying, Nan Jiang, Sushila Maharjan, Yi‐Xia Yin, Rong‐Rong Chai, Xia Cao, Jing‐Zhou Yang, Amir K. Miri, Shabir Hassan, Yu Shrike Zhang

Advanced Materials· Volume 30· Issue 50
Publisher page

Abstract

Abstract 3D bioprinting technology provides programmable and customizable platforms to engineer cell‐laden constructs mimicking human tissues for a wide range of biomedical applications. However, the encapsulated cells are often restricted in spreading and proliferation by dense biomaterial networks from gelation of bioinks. Herein, a cell‐benign approach is reported to directly bioprint porous‐structured hydrogel constructs by using an aqueous two‐phase emulsion bioink. The bioink, which contains two immiscible aqueous phases of cell/gelatin methacryloyl (GelMA) mixture and poly(ethylene oxide) (PEO), is photocrosslinked to fabricate predesigned cell‐laden hydrogel constructs by extrusion bioprinting or digital micromirror device‐based stereolithographic bioprinting. The porous structure of the 3D‐bioprinted hydrogel construct is formed by subsequently removing the PEO phase from the photocrosslinked GelMA hydrogel. Three different cell types (human hepatocellular carcinoma cells, human umbilical vein endothelial cells, and NIH/3T3 mouse embryonic fibroblasts) within the 3D‐bioprinted porous hydrogel patterns show enhanced cell viability, spreading, and proliferation compared to the standard (i.e., nonporous) hydrogel constructs. The 3D bioprinting strategy is believed to provide a robust and versatile platform to engineer porous‐structured tissue constructs and their models for a variety of applications in tissue engineering, regenerative medicine, drug development, and personalized therapeutics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Engineering in Medicine Department of Medicine Brigham and Women's Hospital Harvard Medical School Cambridge MA 02139 USA

School of Materials Science and Engineering Wuhan Institute of Technology Wuhan 430205 P.R. China

School of Engineering and Applied Sciences Harvard University Cambridge MA 02138 USA

Research Institute for Bioscience and Biotechnology Lalitpur 44600 Nepal

State Key Laboratory of Advanced Technology for Materials Synthesis and Processing Wuhan University of Technology Wuhan 430070 P.R. China

Center of Biomedical Materials 3D Printing National Engineering Laboratory for Polymer Complex Structure Additive Manufacturing Baoding 071000 P.R. China

Funding

National Institutes of Health · Natural Science Foundation of Hubei Province

References (51)

Show source-provided references
1. 10.1038/nprot.2016.12310.1038/nprot.2016.123 ↗
2. 10.1002/smll.20150179810.1002/smll.201501798 ↗
3. 10.1016/j.jconrel.2015.08.04910.1016/j.jconrel.2015.08.049 ↗
4. 10.1002/978352768993410.1002/9783527689934 ↗
5. 10.1007/s10439-016-1612-810.1007/s10439-016-1612-8 ↗
6. 10.1002/adma.20160606110.1002/adma.201606061 ↗
7. 10.1016/S0142-9612(03)00340-510.1016/S0142-9612(03)00340-5 ↗
8. 10.1002/adma.20080210610.1002/adma.200802106 ↗
9. 10.1002/bip.2087110.1002/bip.20871 ↗
10. 10.1016/j.biomaterials.2008.09.04110.1016/j.biomaterials.2008.09.041 ↗
11. 10.1016/S0142-9612(00)00201-510.1016/S0142-9612(00)00201-5 ↗
12. 10.1016/j.biomaterials.2005.03.01610.1016/j.biomaterials.2005.03.016 ↗
13. 10.1080/09205063.2018.142642510.1080/09205063.2018.1426425 ↗
14. 10.1016/j.copbio.2016.03.01410.1016/j.copbio.2016.03.014 ↗
15. 10.1002/adma.20160463010.1002/adma.201604630 ↗
16. 10.1002/biot.20140063510.1002/biot.201400635 ↗
17. 10.1038/srep2997710.1038/srep29977 ↗
18. 10.1126/science.106921010.1126/science.1069210 ↗
19. 10.1073/pnas.160735011410.1073/pnas.1607350114 ↗
20. 10.1002/adhm.20180016010.1002/adhm.201800160 ↗
21. 10.1038/nmat440710.1038/nmat4407 ↗
22. 10.1039/C4TC02215G10.1039/C4TC02215G ↗
23. 10.1002/marc.20160023610.1002/marc.201600236 ↗
24. 10.1089/ten.teb.2009.063910.1089/ten.teb.2009.0639 ↗
25. 10.1007/s10853-006-7023-810.1007/s10853-006-7023-8 ↗
26. 10.1002/adma.20050142310.1002/adma.200501423 ↗
27. 10.1038/nmat251510.1038/nmat2515 ↗
28. 10.1039/C8SC01130C10.1039/C8SC01130C ↗
29. 10.1039/C4SC02638A10.1039/C4SC02638A ↗
30. 10.1002/adhm.20160002210.1002/adhm.201600022 ↗
31. Albertsson P.‐A. · 1986
32. 10.1016/0378-4347(96)00042-410.1016/0378-4347(96)00042-4 ↗
33. 10.1016/j.actbio.2010.10.02610.1016/j.actbio.2010.10.026 ↗
34. 10.1007/s11837-016-1969-z10.1007/s11837-016-1969-z ↗
35. 10.1016/j.biomaterials.2015.08.04510.1016/j.biomaterials.2015.08.045 ↗
36. 10.1016/j.tibtech.2016.01.00210.1016/j.tibtech.2016.01.002 ↗
37. 10.1039/C7BM00110J10.1039/C7BM00110J ↗
38. 10.3390/ma910079710.3390/ma9100797 ↗
39. 10.1007/s12195-015-0423-610.1007/s12195-015-0423-6 ↗
40. 10.1016/j.jiec.2017.02.01210.1016/j.jiec.2017.02.012 ↗
41. 10.1016/j.molliq.2014.03.01610.1016/j.molliq.2014.03.016 ↗
42. 10.1016/j.molliq.2013.12.03510.1016/j.molliq.2013.12.035 ↗
43. 10.1002/adhm.20160145110.1002/adhm.201601451 ↗
44. 10.1088/1758-5090/aa9d4410.1088/1758-5090/aa9d44 ↗
45. 10.1002/adma.20180024210.1002/adma.201800242 ↗
46. 10.1021/nn203711s10.1021/nn203711s ↗
47. 10.1002/smll.20130218210.1002/smll.201302182 ↗
48. 10.1016/j.actbio.2012.10.01110.1016/j.actbio.2012.10.011 ↗
49. 10.1021/ma034366i10.1021/ma034366i ↗
50. 10.1016/j.biomaterials.2014.07.01310.1016/j.biomaterials.2014.07.013 ↗
51. 10.1016/j.addr.2012.09.01010.1016/j.addr.2012.09.010 ↗